HEALTHSTREAM INC (HSTM) Fundamental Analysis & Valuation
NASDAQ:HSTM • US42222N1037
Current stock price
21.31 USD
+0.41 (+1.96%)
At close:
21.31 USD
0 (0%)
After Hours:
This HSTM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HSTM Profitability Analysis
1.1 Basic Checks
- HSTM had positive earnings in the past year.
- In the past year HSTM had a positive cash flow from operations.
- Each year in the past 5 years HSTM has been profitable.
- Each year in the past 5 years HSTM had a positive operating cash flow.
1.2 Ratios
- HSTM has a better Return On Assets (3.52%) than 82.86% of its industry peers.
- Looking at the Return On Equity, with a value of 5.18%, HSTM belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
- HSTM has a better Return On Invested Capital (4.08%) than 77.14% of its industry peers.
- HSTM had an Average Return On Invested Capital over the past 3 years of 3.91%. This is below the industry average of 7.46%.
- The last Return On Invested Capital (4.08%) for HSTM is above the 3 year average (3.91%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 5.18% | ||
| ROIC | 4.08% |
ROA(3y)3.49%
ROA(5y)2.82%
ROE(3y)5.07%
ROE(5y)4.11%
ROIC(3y)3.91%
ROIC(5y)3.2%
1.3 Margins
- With an excellent Profit Margin value of 6.03%, HSTM belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
- In the last couple of years the Profit Margin of HSTM has remained more or less at the same level.
- Looking at the Operating Margin, with a value of 6.65%, HSTM is in the better half of the industry, outperforming 77.14% of the companies in the same industry.
- In the last couple of years the Operating Margin of HSTM has remained more or less at the same level.
- With a Gross Margin value of 64.74%, HSTM perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
- In the last couple of years the Gross Margin of HSTM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.65% | ||
| PM (TTM) | 6.03% | ||
| GM | 64.74% |
OM growth 3Y12.71%
OM growth 5Y0.62%
PM growth 3Y9.98%
PM growth 5Y0.93%
GM growth 3Y-0.57%
GM growth 5Y0.38%
2. HSTM Health Analysis
2.1 Basic Checks
- HSTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for HSTM has been reduced compared to 1 year ago.
- Compared to 5 years ago, HSTM has less shares outstanding
- There is no outstanding debt for HSTM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- HSTM has an Altman-Z score of 3.24. This indicates that HSTM is financially healthy and has little risk of bankruptcy at the moment.
- HSTM's Altman-Z score of 3.24 is fine compared to the rest of the industry. HSTM outperforms 77.14% of its industry peers.
- HSTM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.24 |
ROIC/WACC0.45
WACC8.99%
2.3 Liquidity
- HSTM has a Current Ratio of 0.96. This is a bad value and indicates that HSTM is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Current ratio of HSTM (0.96) is worse than 85.71% of its industry peers.
- HSTM has a Quick Ratio of 0.96. This is a bad value and indicates that HSTM is not financially healthy enough and could expect problems in meeting its short term obligations.
- HSTM's Quick ratio of 0.96 is on the low side compared to the rest of the industry. HSTM is outperformed by 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.96 |
3. HSTM Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 6.06% over the past year.
- Measured over the past years, HSTM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.23% on average per year.
- HSTM shows a small growth in Revenue. In the last year, the Revenue has grown by 4.26%.
- HSTM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.43% yearly.
EPS 1Y (TTM)6.06%
EPS 3Y21.53%
EPS 5Y16.23%
EPS Q2Q%12.5%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y4.45%
Revenue growth 5Y4.43%
Sales Q2Q%7.37%
3.2 Future
- The Earnings Per Share is expected to grow by 9.31% on average over the next years. This is quite good.
- HSTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.81% yearly.
EPS Next Y6.66%
EPS Next 2Y9.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.55%
Revenue Next 2Y6.82%
Revenue Next 3Y4.19%
Revenue Next 5Y4.81%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. HSTM Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 30.44, the valuation of HSTM can be described as expensive.
- 71.43% of the companies in the same industry are more expensive than HSTM, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 27.42, HSTM is valued at the same level.
- The Price/Forward Earnings ratio is 28.54, which means the current valuation is very expensive for HSTM.
- HSTM's Price/Forward Earnings ratio is in line with the industry average.
- The average S&P500 Price/Forward Earnings ratio is at 22.24. HSTM is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.44 | ||
| Fwd PE | 28.54 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HSTM is valued cheaply inside the industry as 82.86% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of HSTM indicates a somewhat cheap valuation: HSTM is cheaper than 65.71% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.05 | ||
| EV/EBITDA | 8.39 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of HSTM may justify a higher PE ratio.
PEG (NY)4.57
PEG (5Y)1.88
EPS Next 2Y9.31%
EPS Next 3YN/A
5. HSTM Dividend Analysis
5.1 Amount
- HSTM has a yearly dividend return of 0.60%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.57, HSTM pays a better dividend. On top of this HSTM pays more dividend than 91.43% of the companies listed in the same industry.
- With a Dividend Yield of 0.60, HSTM pays less dividend than the S&P500 average, which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.6% |
5.2 History
- The dividend of HSTM is nicely growing with an annual growth rate of 148.95%!
- HSTM has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)148.95%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- 20.33% of the earnings are spent on dividend by HSTM. This is a low number and sustainable payout ratio.
- The dividend of HSTM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP20.33%
EPS Next 2Y9.31%
EPS Next 3YN/A
HSTM Fundamentals: All Metrics, Ratios and Statistics
21.31
+0.41 (+1.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-23 2026-02-23/amc
Earnings (Next)04-27 2026-04-27
Inst Owners74.13%
Inst Owner Change-0.15%
Ins Owners17.27%
Ins Owner Change-21.88%
Market Cap624.60M
Revenue(TTM)304.06M
Net Income(TTM)18.34M
Analysts78.18
Price Target21.42 (0.52%)
Short Float %3.73%
Short Ratio2.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.6% |
Yearly Dividend0.12
Dividend Growth(5Y)148.95%
DP20.33%
Div Incr Years2
Div Non Decr Years2
Ex-Date03-09 2026-03-09 (0.035)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.92%
Min EPS beat(2)11.41%
Max EPS beat(2)60.43%
EPS beat(4)3
Avg EPS beat(4)18.24%
Min EPS beat(4)-12.02%
Max EPS beat(4)60.43%
EPS beat(8)7
Avg EPS beat(8)25.3%
EPS beat(12)11
Avg EPS beat(12)29.71%
EPS beat(16)15
Avg EPS beat(16)53.52%
Revenue beat(2)1
Avg Revenue beat(2)0.91%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)2.56%
Revenue beat(4)1
Avg Revenue beat(4)-1%
Min Revenue beat(4)-3.85%
Max Revenue beat(4)2.56%
Revenue beat(8)1
Avg Revenue beat(8)-1.5%
Revenue beat(12)1
Avg Revenue beat(12)-1.71%
Revenue beat(16)1
Avg Revenue beat(16)-1.92%
PT rev (1m)-35.38%
PT rev (3m)-35.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.14%
EPS NY rev (1m)-2.4%
EPS NY rev (3m)-3.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.44 | ||
| Fwd PE | 28.54 | ||
| P/S | 2.05 | ||
| P/FCF | 20.05 | ||
| P/OCF | 9.86 | ||
| P/B | 1.76 | ||
| P/tB | 24.03 | ||
| EV/EBITDA | 8.39 |
EPS(TTM)0.7
EY3.28%
EPS(NY)0.75
Fwd EY3.5%
FCF(TTM)1.06
FCFY4.99%
OCF(TTM)2.16
OCFY10.14%
SpS10.37
BVpS12.08
TBVpS0.89
PEG (NY)4.57
PEG (5Y)1.88
Graham Number13.7927 (-35.28%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 5.18% | ||
| ROCE | 5.11% | ||
| ROIC | 4.08% | ||
| ROICexc | 4.76% | ||
| ROICexgc | 144.29% | ||
| OM | 6.65% | ||
| PM (TTM) | 6.03% | ||
| GM | 64.74% | ||
| FCFM | 10.25% |
ROA(3y)3.49%
ROA(5y)2.82%
ROE(3y)5.07%
ROE(5y)4.11%
ROIC(3y)3.91%
ROIC(5y)3.2%
ROICexc(3y)4.86%
ROICexc(5y)3.91%
ROICexgc(3y)162.5%
ROICexgc(5y)114.53%
ROCE(3y)4.9%
ROCE(5y)4.01%
ROICexgc growth 3Y31.22%
ROICexgc growth 5Y26.84%
ROICexc growth 3Y16.25%
ROICexc growth 5Y4.77%
OM growth 3Y12.71%
OM growth 5Y0.62%
PM growth 3Y9.98%
PM growth 5Y0.93%
GM growth 3Y-0.57%
GM growth 5Y0.38%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 73.98% | ||
| Cap/Sales | 10.58% | ||
| Interest Coverage | 200.35 | ||
| Cash Conversion | 99.38% | ||
| Profit Quality | 169.87% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 3.24 |
F-Score6
WACC8.99%
ROIC/WACC0.45
Cap/Depr(3y)70.13%
Cap/Depr(5y)69.08%
Cap/Sales(3y)10.09%
Cap/Sales(5y)9.91%
Profit Quality(3y)184.6%
Profit Quality(5y)212.64%
High Growth Momentum
Growth
EPS 1Y (TTM)6.06%
EPS 3Y21.53%
EPS 5Y16.23%
EPS Q2Q%12.5%
EPS Next Y6.66%
EPS Next 2Y9.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.26%
Revenue growth 3Y4.45%
Revenue growth 5Y4.43%
Sales Q2Q%7.37%
Revenue Next Year8.55%
Revenue Next 2Y6.82%
Revenue Next 3Y4.19%
Revenue Next 5Y4.81%
EBIT growth 1Y-4.95%
EBIT growth 3Y17.73%
EBIT growth 5Y5.07%
EBIT Next Year261.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.55%
FCF growth 3Y6.09%
FCF growth 5Y12.79%
OCF growth 1Y9.81%
OCF growth 3Y7.35%
OCF growth 5Y12.04%
HEALTHSTREAM INC / HSTM Fundamental Analysis FAQ
What is the fundamental rating for HSTM stock?
ChartMill assigns a fundamental rating of 5 / 10 to HSTM.
What is the valuation status for HSTM stock?
ChartMill assigns a valuation rating of 4 / 10 to HEALTHSTREAM INC (HSTM). This can be considered as Fairly Valued.
How profitable is HEALTHSTREAM INC (HSTM) stock?
HEALTHSTREAM INC (HSTM) has a profitability rating of 7 / 10.
What is the valuation of HEALTHSTREAM INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for HEALTHSTREAM INC (HSTM) is 30.44 and the Price/Book (PB) ratio is 1.76.
Can you provide the dividend sustainability for HSTM stock?
The dividend rating of HEALTHSTREAM INC (HSTM) is 4 / 10 and the dividend payout ratio is 20.33%.